147 related articles for article (PubMed ID: 3471317)
1. Presence of cytidine 5'-monophospho-N-acetylneuraminic acid:Gal beta 1-3GalNAc-R alpha(2-3)-sialyltransferase in normal human leukocytes and increased activity of this enzyme in granulocytes from chronic myelogenous leukemia patients.
Baker MA; Kanani A; Brockhausen I; Schachter H; Hindenburg A; Taub RN
Cancer Res; 1987 Jun; 47(11):2763-6. PubMed ID: 3471317
[TBL] [Abstract][Full Text] [Related]
2. Increased activity of a specific sialyltransferase in chronic myelogenous leukemia.
Baker MA; Taub RN; Kanani A; Brockhausen I; Hindenburg A
Blood; 1985 Nov; 66(5):1068-71. PubMed ID: 2413927
[TBL] [Abstract][Full Text] [Related]
3. Human leukemic myeloblasts and myeloblastoid cells contain the enzyme cytidine 5'-monophosphate-N-acetylneuraminic acid:Gal beta 1-3GalNAc alpha (2-3)-sialyltransferase.
Kanani A; Sutherland DR; Fibach E; Matta KL; Hindenburg A; Brockhausen I; Kuhns W; Taub RN; van den Eijnden DH; Baker MA
Cancer Res; 1990 Aug; 50(16):5003-7. PubMed ID: 2379165
[TBL] [Abstract][Full Text] [Related]
4. Donor substrate specificities of Gal beta 1,4GlcNAc alpha 2,6-sialyltransferase and Gal beta 1,3GalNAc alpha 2,3-sialyltransferase: comparison of N-acetyl and N-glycolylneuraminic acids.
Hamamoto T; Kurosawa N; Lee YC; Tsuji S
Biochim Biophys Acta; 1995 May; 1244(1):223-8. PubMed ID: 7766662
[TBL] [Abstract][Full Text] [Related]
5. Purification and enzymatic characterization of CMP-sialic acid: beta-galactosyl1----3-N-acetylgalactosaminide alpha 2----3-sialyltransferase from human placenta.
Joziasse DH; Bergh ML; ter Hart HG; Koppen PL; Hooghwinkel GJ; Van den Eijnden DH
J Biol Chem; 1985 Apr; 260(8):4941-51. PubMed ID: 3988739
[TBL] [Abstract][Full Text] [Related]
6. Branch specificity of bovine colostrum CMP-sialic acid: Gal beta 1----4GlcNAc-R alpha 2----6-sialyltransferase. Sialylation of bi-, tri-, and tetraantennary oligosaccharides and glycopeptides of the N-acetyllactosamine type.
Joziasse DH; Schiphorst WE; Van den Eijnden DH; Van Kuik JA; Van Halbeek H; Vliegenthart JF
J Biol Chem; 1987 Feb; 262(5):2025-33. PubMed ID: 3546284
[TBL] [Abstract][Full Text] [Related]
7. Processing O-glycan core 1, Gal beta 1-3GalNAc alpha-R. Specificities of core 2, UDP-GlcNAc: Gal beta 1-3 GalNAc-R(GlcNAc to GalNAc) beta 6-N-acetylglucosaminyltransferase and CMP-sialic acid: Gal beta 1-3GalNAc-R alpha 3-sialyltransferase.
Kuhns W; Rutz V; Paulsen H; Matta KL; Baker MA; Barner M; Granovsky M; Brockhausen I
Glycoconj J; 1993 Oct; 10(5):381-94. PubMed ID: 8298305
[TBL] [Abstract][Full Text] [Related]
8. Evidence for an O-glycan sialylation system in brain. Characterization of a beta-galactoside alpha 2,3-sialyltransferase from rat brain regulating the expression of an alpha-N-acetylgalactosaminide alpha 2,6-sialyltransferase activity.
Baubichon-Cortay H; Broquet P; George P; Louisot P
Eur J Biochem; 1989 Jun; 182(2):257-65. PubMed ID: 2472271
[TBL] [Abstract][Full Text] [Related]
9. Reversible sialylation: synthesis of cytidine 5'-monophospho-N-acetylneuraminic acid from cytidine 5'-monophosphate with alpha2,3-sialyl O-glycan-, glycolipid-, and macromolecule-based donors yields diverse sialylated products.
Chandrasekaran EV; Xue J; Xia J; Locke RD; Matta KL; Neelamegham S
Biochemistry; 2008 Jan; 47(1):320-30. PubMed ID: 18067323
[TBL] [Abstract][Full Text] [Related]
10. Enzymatic synthesis of unique sialyloligosaccharides using marine bacterial alpha-(2-->3)- and alpha-(2-->6)-sialyltransferases.
Mine T; Miyazaki T; Kajiwara H; Naito K; Ajisaka K; Yamamoto T
Carbohydr Res; 2010 Jul; 345(10):1417-21. PubMed ID: 20413108
[TBL] [Abstract][Full Text] [Related]
11. Alpha-(2-->3)- and alpha-(2-->6)-sialyltransferase activities present in three variants of Ehrlich tumor cells: identification of the products derived from N-acetyllactosamine and beta-D-Gal-(1-->3)-alpha-D-GalNAc-(1-->O)-Bn.
Shigeta S; Winter HC; Goldstein IJ
Carbohydr Res; 1994 Nov; 264(1):111-21. PubMed ID: 8001013
[TBL] [Abstract][Full Text] [Related]
12. Glycoengineering of therapeutic glycoproteins: in vitro galactosylation and sialylation of glycoproteins with terminal N-acetylglucosamine and galactose residues.
Raju TS; Briggs JB; Chamow SM; Winkler ME; Jones AJ
Biochemistry; 2001 Jul; 40(30):8868-76. PubMed ID: 11467948
[TBL] [Abstract][Full Text] [Related]
13. Ecto-sialyltransferase of human B lymphocytes reconstitutes differentiation markers in the presence of exogenous CMP-N-acetyl neuraminic acid.
Gross HJ; Merling A; Moldenhauer G; Schwartz-Albiez R
Blood; 1996 Jun; 87(12):5113-26. PubMed ID: 8652824
[TBL] [Abstract][Full Text] [Related]
14. A Pasteurella multocida sialyltransferase displaying dual trans-sialidase activities for production of 3'-sialyl and 6'-sialyl glycans.
Guo Y; Jers C; Meyer AS; Arnous A; Li H; Kirpekar F; Mikkelsen JD
J Biotechnol; 2014 Jan; 170():60-7. PubMed ID: 24291191
[TBL] [Abstract][Full Text] [Related]
15. Role of aberrant sialylation of chronic myeloid leukemia granulocytes on binding and signal transduction by chemotactic peptides and colony stimulating factors.
Cyopick P; Culliton R; Brockhausen I; Sutherland DR; Mills GB; Baker M
Leuk Lymphoma; 1993 Sep; 11(1-2):79-90. PubMed ID: 8220157
[TBL] [Abstract][Full Text] [Related]
16. Biosynthesis of mammalian glycoproteins. Glycosylation pathways in the synthesis of the nonreducing terminal sequences.
Beyer TA; Rearick JI; Paulson JC; Prieels JP; Sadler JE; Hill RL
J Biol Chem; 1979 Dec; 254(24):12531-4. PubMed ID: 500730
[TBL] [Abstract][Full Text] [Related]
17. Discrimination between activity of (alpha 2-3)-sialyltransferase and (alpha 2-6)-sialyltransferase in human platelets using p-nitrophenyl-beta-D-galactoside as acceptor.
Bauvois B; Cacan R; Fournet B; Caen J; Montreuil J; Verbert A
Eur J Biochem; 1982 Jan; 121(3):567-72. PubMed ID: 7035171
[TBL] [Abstract][Full Text] [Related]
18. Comparative rates of transfer of N-acetylneuraminic acid to acceptors bearing one or more Gal(beta 1-4)GlcNAc terminus by the Gal(beta 1-4)GlcNAc(NeuAc-Gal) (alpha 2-6)-sialyltransferase from embryonic chicken liver. Utilization of oligosaccharides as acceptors in sialyltransferase assays.
Bendiak B; Cook GM
Biochem J; 1983 Jul; 213(1):253-60. PubMed ID: 6615429
[TBL] [Abstract][Full Text] [Related]
19. The polypeptide part of human chorionic gonadotrophin affects the kinetics of alpha 6-sialylation of its N-linked glycans but does not alter the branch specificity of CMP-NeuAc:Gal beta 1----4GlcNAc-R alpha 2----6-sialyltransferase.
Nemansky M; Edzes HT; Wijnands RA; Van den Eijnden DH
Glycobiology; 1992 Apr; 2(2):109-17. PubMed ID: 1606356
[TBL] [Abstract][Full Text] [Related]
20. Determination of the specificities of rat liver Gal(beta 1-4)GlcNAc alpha 2,6-sialyltransferase and Gal(beta 1-3/4)GlcNAc alpha 2,3-sialyltransferase using synthetic modified acceptors.
Wlasichuk KB; Kashem MA; Nikrad PV; Bird P; Jiang C; Venot AP
J Biol Chem; 1993 Jul; 268(19):13971-7. PubMed ID: 8314763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
